Trump Administration Halts Medicare Payments in California, Citing Fraud Concerns

WASHINGTON — The Trump administration announced Thursday that it will suspend all Medicare payments to providers in California, citing concerns about potential fraud risks, despite acknowledging there is no current evidence of wrongdoing in the state.

Speaking on behalf of the administration, Vice President JD Vance pointed to a recent Department of Justice case in Florida involving HealthSplash, a healthcare company accused of large-scale Medicare fraud. Federal prosecutors allege that the company submitted fraudulent claims for services that were either unnecessary or never provided, resulting in significant financial losses to the federal government.

Vance said the Florida case illustrates broader vulnerabilities within the Medicare system. “What we are seeing in Florida is not necessarily isolated,” he said during a press briefing. “Even in places where we don’t yet have active investigations, the structural conditions exist for bad actors to attempt to exploit the system.”

The administration’s decision to suspend payments in California marks a significant escalation in its approach to combating healthcare fraud. Officials said the move is intended as a preventive measure while federal agencies conduct a comprehensive review of billing practices and oversight mechanisms in the state.

According to administration officials, the suspension will remain in effect until further notice, pending the outcome of internal assessments by the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS).

Healthcare providers and state officials in California reacted with concern, noting that the decision could disrupt care for millions of Medicare beneficiaries. California is home to one of the largest Medicare populations in the country, including seniors and individuals with disabilities who rely on the program for essential medical services.

In a statement, a spokesperson for the California Department of Health Care Services said there is “no evidence of widespread fraud within the state’s Medicare system” and warned that halting payments could create “immediate financial strain on hospitals, clinics, and providers.”

Policy analysts also raised questions about the scope of the action. Some experts noted that while Medicare fraud remains a persistent issue nationwide, enforcement actions are typically targeted at specific entities rather than entire states.

The Department of Justice declined to comment on whether any investigations related to California are currently underway. Meanwhile, CMS officials said they are working to develop contingency plans to minimize disruption to patient care.

The administration did not provide a timeline for when payments might resume, stating only that the review process would proceed “as quickly as possible while ensuring program integrity.”

Medicare payments in Florida have not been affected.